P.127 Quality of life (QoL) using EORTC QoL-C30 and BN20 among patients who underwent brain tumor resection in a tertiary hospital in Saudi Arabia
Background: Quality of life (QoL) is the awareness of individuals’ well-being in life in physical, personal, mental and social wellbeing and needs to be addressed in brain tumor patients. Methods: A retrospective study conducted in 2017 in a single academic center that included patients diagnosed wi...
Gespeichert in:
Veröffentlicht in: | Canadian journal of neurological sciences 2024-06, Vol.51 (s1), p.S50-S51 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | S51 |
---|---|
container_issue | s1 |
container_start_page | S50 |
container_title | Canadian journal of neurological sciences |
container_volume | 51 |
creator | Moshref, R Moshref, L Sabbagh, AJ Bajunaid, K Alyousef, M Baeesa, S Daghistani, R Alhalawani, FA Aljehani, MA Shibriq, NM Saber, WA Khojah, AB Alsayed, RM |
description | Background: Quality of life (QoL) is the awareness of individuals’ well-being in life in physical, personal, mental and social wellbeing and needs to be addressed in brain tumor patients. Methods: A retrospective study conducted in 2017 in a single academic center that included patients diagnosed with brain tumors in a 10 year period. The assessment of the QoL was done using the European Organization for Research and Treatment of Cancer (EORTC), a standardized model (QLQ-C30) that assess several domains (Global Health, Physical function, Role functioning, Emotional Functioning, Cognitive functioning, social functioning and symptoms domain) and Brain cancer model (BN20) to assess symptoms to evaluate all aspects of wellbeing. Results: The total number of patients included in this study is 76 patients with no gender predilection. The most common brain tumor was meningioma by 40% followed by glioma/ others. More than half of the brain tumor patients had a WHO grade I (65%), intermediate grading grade II (15%) and higher grading grade III/IV (20%). The scales and measurements of functioning in life were low in all types of brain tumors. Conclusions: Quality of life in brain tumor patients seemed poor regardless of the type. Further prospective studies are needed to assess QoL worldwide. |
doi_str_mv | 10.1017/cjn.2024.228 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3059005227</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_cjn_2024_228</cupid><sourcerecordid>3059005227</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1428-c2456bb325c8f68ad9bfaac622ca4803ac90e82d3d6f6208f2d19ca2fda4d6733</originalsourceid><addsrcrecordid>eNptkE1P3DAQhi1EJRbKjR8wEheQSGpPEid7hBW0lValFDhHE3-AV7vxYjtC_I3-4noFEpeeZuaddz70MHYieCm4aL-p1Vgix7pE7PbYDHnTFlw0zT6b8Uq0hZCtOGCHMa44R9nIesb-_i4FtnA30dqlN_AW1s4aOLvzy3OYohuf4Pr2z8MCslAsKg40arj6hTnZ-NzcUnJmTBFenz1MozbhNZcwBHIjpGnjAwQTjUrOj5AlgmRCchTe4NnHrUu03sn3NGkHl4EGR1_ZF0vraI4_4hF7vLl-WPwolrfffy4ul4USNXaFwrqRw1BhozorO9LzwRIpiaio7nhFas5Nh7rS0krknUUt5orQaqq1bKvqiJ2-790G_zKZmPqVn8KYT_YVb-acN4htdl28u1TwMQZj-21wm_x_L3i_o95n6v2Oep-pZ3v5YafNEJx-Mp9b_zvwD30qgxg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3059005227</pqid></control><display><type>article</type><title>P.127 Quality of life (QoL) using EORTC QoL-C30 and BN20 among patients who underwent brain tumor resection in a tertiary hospital in Saudi Arabia</title><source>Cambridge Journals</source><creator>Moshref, R ; Moshref, L ; Sabbagh, AJ ; Bajunaid, K ; Alyousef, M ; Baeesa, S ; Daghistani, R ; Alhalawani, FA ; Aljehani, MA ; Shibriq, NM ; Saber, WA ; Khojah, AB ; Alsayed, RM</creator><creatorcontrib>Moshref, R ; Moshref, L ; Sabbagh, AJ ; Bajunaid, K ; Alyousef, M ; Baeesa, S ; Daghistani, R ; Alhalawani, FA ; Aljehani, MA ; Shibriq, NM ; Saber, WA ; Khojah, AB ; Alsayed, RM</creatorcontrib><description>Background: Quality of life (QoL) is the awareness of individuals’ well-being in life in physical, personal, mental and social wellbeing and needs to be addressed in brain tumor patients. Methods: A retrospective study conducted in 2017 in a single academic center that included patients diagnosed with brain tumors in a 10 year period. The assessment of the QoL was done using the European Organization for Research and Treatment of Cancer (EORTC), a standardized model (QLQ-C30) that assess several domains (Global Health, Physical function, Role functioning, Emotional Functioning, Cognitive functioning, social functioning and symptoms domain) and Brain cancer model (BN20) to assess symptoms to evaluate all aspects of wellbeing. Results: The total number of patients included in this study is 76 patients with no gender predilection. The most common brain tumor was meningioma by 40% followed by glioma/ others. More than half of the brain tumor patients had a WHO grade I (65%), intermediate grading grade II (15%) and higher grading grade III/IV (20%). The scales and measurements of functioning in life were low in all types of brain tumors. Conclusions: Quality of life in brain tumor patients seemed poor regardless of the type. Further prospective studies are needed to assess QoL worldwide.</description><identifier>ISSN: 0317-1671</identifier><identifier>EISSN: 2057-0155</identifier><identifier>DOI: 10.1017/cjn.2024.228</identifier><language>eng</language><publisher>New York, USA: Cambridge University Press</publisher><subject>Abstracts ; Brain cancer ; Neurosurgery (CNSS) ; Other Multidisciplinary ; Poster Presentations ; Quality of life ; Tumors ; Well being</subject><ispartof>Canadian journal of neurological sciences, 2024-06, Vol.51 (s1), p.S50-S51</ispartof><rights>The Author(s), 2024. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S0317167124002282/type/journal_article$$EHTML$$P50$$Gcambridge$$H</linktohtml><link.rule.ids>164,314,778,782,27911,27912,55615</link.rule.ids></links><search><creatorcontrib>Moshref, R</creatorcontrib><creatorcontrib>Moshref, L</creatorcontrib><creatorcontrib>Sabbagh, AJ</creatorcontrib><creatorcontrib>Bajunaid, K</creatorcontrib><creatorcontrib>Alyousef, M</creatorcontrib><creatorcontrib>Baeesa, S</creatorcontrib><creatorcontrib>Daghistani, R</creatorcontrib><creatorcontrib>Alhalawani, FA</creatorcontrib><creatorcontrib>Aljehani, MA</creatorcontrib><creatorcontrib>Shibriq, NM</creatorcontrib><creatorcontrib>Saber, WA</creatorcontrib><creatorcontrib>Khojah, AB</creatorcontrib><creatorcontrib>Alsayed, RM</creatorcontrib><title>P.127 Quality of life (QoL) using EORTC QoL-C30 and BN20 among patients who underwent brain tumor resection in a tertiary hospital in Saudi Arabia</title><title>Canadian journal of neurological sciences</title><addtitle>Can. J. Neurol. Sci</addtitle><description>Background: Quality of life (QoL) is the awareness of individuals’ well-being in life in physical, personal, mental and social wellbeing and needs to be addressed in brain tumor patients. Methods: A retrospective study conducted in 2017 in a single academic center that included patients diagnosed with brain tumors in a 10 year period. The assessment of the QoL was done using the European Organization for Research and Treatment of Cancer (EORTC), a standardized model (QLQ-C30) that assess several domains (Global Health, Physical function, Role functioning, Emotional Functioning, Cognitive functioning, social functioning and symptoms domain) and Brain cancer model (BN20) to assess symptoms to evaluate all aspects of wellbeing. Results: The total number of patients included in this study is 76 patients with no gender predilection. The most common brain tumor was meningioma by 40% followed by glioma/ others. More than half of the brain tumor patients had a WHO grade I (65%), intermediate grading grade II (15%) and higher grading grade III/IV (20%). The scales and measurements of functioning in life were low in all types of brain tumors. Conclusions: Quality of life in brain tumor patients seemed poor regardless of the type. Further prospective studies are needed to assess QoL worldwide.</description><subject>Abstracts</subject><subject>Brain cancer</subject><subject>Neurosurgery (CNSS)</subject><subject>Other Multidisciplinary</subject><subject>Poster Presentations</subject><subject>Quality of life</subject><subject>Tumors</subject><subject>Well being</subject><issn>0317-1671</issn><issn>2057-0155</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNptkE1P3DAQhi1EJRbKjR8wEheQSGpPEid7hBW0lValFDhHE3-AV7vxYjtC_I3-4noFEpeeZuaddz70MHYieCm4aL-p1Vgix7pE7PbYDHnTFlw0zT6b8Uq0hZCtOGCHMa44R9nIesb-_i4FtnA30dqlN_AW1s4aOLvzy3OYohuf4Pr2z8MCslAsKg40arj6hTnZ-NzcUnJmTBFenz1MozbhNZcwBHIjpGnjAwQTjUrOj5AlgmRCchTe4NnHrUu03sn3NGkHl4EGR1_ZF0vraI4_4hF7vLl-WPwolrfffy4ul4USNXaFwrqRw1BhozorO9LzwRIpiaio7nhFas5Nh7rS0krknUUt5orQaqq1bKvqiJ2-790G_zKZmPqVn8KYT_YVb-acN4htdl28u1TwMQZj-21wm_x_L3i_o95n6v2Oep-pZ3v5YafNEJx-Mp9b_zvwD30qgxg</recordid><startdate>202406</startdate><enddate>202406</enddate><creator>Moshref, R</creator><creator>Moshref, L</creator><creator>Sabbagh, AJ</creator><creator>Bajunaid, K</creator><creator>Alyousef, M</creator><creator>Baeesa, S</creator><creator>Daghistani, R</creator><creator>Alhalawani, FA</creator><creator>Aljehani, MA</creator><creator>Shibriq, NM</creator><creator>Saber, WA</creator><creator>Khojah, AB</creator><creator>Alsayed, RM</creator><general>Cambridge University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope></search><sort><creationdate>202406</creationdate><title>P.127 Quality of life (QoL) using EORTC QoL-C30 and BN20 among patients who underwent brain tumor resection in a tertiary hospital in Saudi Arabia</title><author>Moshref, R ; Moshref, L ; Sabbagh, AJ ; Bajunaid, K ; Alyousef, M ; Baeesa, S ; Daghistani, R ; Alhalawani, FA ; Aljehani, MA ; Shibriq, NM ; Saber, WA ; Khojah, AB ; Alsayed, RM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1428-c2456bb325c8f68ad9bfaac622ca4803ac90e82d3d6f6208f2d19ca2fda4d6733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Abstracts</topic><topic>Brain cancer</topic><topic>Neurosurgery (CNSS)</topic><topic>Other Multidisciplinary</topic><topic>Poster Presentations</topic><topic>Quality of life</topic><topic>Tumors</topic><topic>Well being</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moshref, R</creatorcontrib><creatorcontrib>Moshref, L</creatorcontrib><creatorcontrib>Sabbagh, AJ</creatorcontrib><creatorcontrib>Bajunaid, K</creatorcontrib><creatorcontrib>Alyousef, M</creatorcontrib><creatorcontrib>Baeesa, S</creatorcontrib><creatorcontrib>Daghistani, R</creatorcontrib><creatorcontrib>Alhalawani, FA</creatorcontrib><creatorcontrib>Aljehani, MA</creatorcontrib><creatorcontrib>Shibriq, NM</creatorcontrib><creatorcontrib>Saber, WA</creatorcontrib><creatorcontrib>Khojah, AB</creatorcontrib><creatorcontrib>Alsayed, RM</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><jtitle>Canadian journal of neurological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moshref, R</au><au>Moshref, L</au><au>Sabbagh, AJ</au><au>Bajunaid, K</au><au>Alyousef, M</au><au>Baeesa, S</au><au>Daghistani, R</au><au>Alhalawani, FA</au><au>Aljehani, MA</au><au>Shibriq, NM</au><au>Saber, WA</au><au>Khojah, AB</au><au>Alsayed, RM</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P.127 Quality of life (QoL) using EORTC QoL-C30 and BN20 among patients who underwent brain tumor resection in a tertiary hospital in Saudi Arabia</atitle><jtitle>Canadian journal of neurological sciences</jtitle><addtitle>Can. J. Neurol. Sci</addtitle><date>2024-06</date><risdate>2024</risdate><volume>51</volume><issue>s1</issue><spage>S50</spage><epage>S51</epage><pages>S50-S51</pages><issn>0317-1671</issn><eissn>2057-0155</eissn><abstract>Background: Quality of life (QoL) is the awareness of individuals’ well-being in life in physical, personal, mental and social wellbeing and needs to be addressed in brain tumor patients. Methods: A retrospective study conducted in 2017 in a single academic center that included patients diagnosed with brain tumors in a 10 year period. The assessment of the QoL was done using the European Organization for Research and Treatment of Cancer (EORTC), a standardized model (QLQ-C30) that assess several domains (Global Health, Physical function, Role functioning, Emotional Functioning, Cognitive functioning, social functioning and symptoms domain) and Brain cancer model (BN20) to assess symptoms to evaluate all aspects of wellbeing. Results: The total number of patients included in this study is 76 patients with no gender predilection. The most common brain tumor was meningioma by 40% followed by glioma/ others. More than half of the brain tumor patients had a WHO grade I (65%), intermediate grading grade II (15%) and higher grading grade III/IV (20%). The scales and measurements of functioning in life were low in all types of brain tumors. Conclusions: Quality of life in brain tumor patients seemed poor regardless of the type. Further prospective studies are needed to assess QoL worldwide.</abstract><cop>New York, USA</cop><pub>Cambridge University Press</pub><doi>10.1017/cjn.2024.228</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0317-1671 |
ispartof | Canadian journal of neurological sciences, 2024-06, Vol.51 (s1), p.S50-S51 |
issn | 0317-1671 2057-0155 |
language | eng |
recordid | cdi_proquest_journals_3059005227 |
source | Cambridge Journals |
subjects | Abstracts Brain cancer Neurosurgery (CNSS) Other Multidisciplinary Poster Presentations Quality of life Tumors Well being |
title | P.127 Quality of life (QoL) using EORTC QoL-C30 and BN20 among patients who underwent brain tumor resection in a tertiary hospital in Saudi Arabia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T18%3A25%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P.127%20Quality%20of%20life%20(QoL)%20using%20EORTC%20QoL-C30%20and%20BN20%20among%20patients%20who%20underwent%20brain%20tumor%20resection%20in%20a%20tertiary%20hospital%20in%20Saudi%20Arabia&rft.jtitle=Canadian%20journal%20of%20neurological%20sciences&rft.au=Moshref,%20R&rft.date=2024-06&rft.volume=51&rft.issue=s1&rft.spage=S50&rft.epage=S51&rft.pages=S50-S51&rft.issn=0317-1671&rft.eissn=2057-0155&rft_id=info:doi/10.1017/cjn.2024.228&rft_dat=%3Cproquest_cross%3E3059005227%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3059005227&rft_id=info:pmid/&rft_cupid=10_1017_cjn_2024_228&rfr_iscdi=true |